Nouveaux membres
New sponsor member - AFYX
The Chamber is honoured to announce that AFYX has decided to join our main partner network as a new sponsor member.
At AFYX - Reversed Innovation is our core value.
As a leader in the biopharmaceutical industry, reversed innovation aligns with our broader theme, as we take an existing product or technology and use it to address a new or previously overlooked or unconsidered medical problem or condition. For more information please click here.
Dr. Claus J. Møller-San Pedro is the company CEO. Dr. Møller co-founded and secured successful IPOs of 3 companies in the BioPharma Industry (OXiGENE, Inc; Genmab A/S and Y-mAbs Therapeutics, Inc.)
AFYX, via Pia Laursen, Board Member & SVP Marketing & Logistics at AFYX will chair the new committee that the Chamber will launch in a few weeks: a life science committee. If you are interested in joining this committee please contact us. More information coming soon.
